InSights Videos Pricing and Market Access in PartneringJan 30, 2024How Small/Mid-Size Firms are Shaping the Healthcare M&A MarketJun 16, 2022What is driving consolidation in the pharmaceutical contract services industry?Dec 1, 2021Innovation in the Race to Develop COVID-19 VaccinesSep 8, 2021How to achieve success in deal makingAug 6, 2021How is M&A Shifting the Pharma Manufacturing Landscape?Jun 25, 2021Contract Manufacturing in the Pharmaceutical Industry: RecipharmMar 29, 2021PharmaVentures InSights: The impact of conference cancellations on dealmaking during the Covid-19 pandemicNov 11, 2020The Divestment Challenge InterviewOct 22, 2020Doing deals in the healthcare sector during the Covid-19 pandemic.Apr 6, 2020Key Questions When Doing a Deal with Big Pharma: A Conversation with PharmaVentures (한국어 버전)Aug 31, 2018Why you should make South Korea a deal making targetAug 2, 2018Video Interview: NetScientific, Fighting chronic diseases on three fronts.Mar 19, 2018 Featured Videos Manufacturing Operations Divestment Expertisefind out moreVisit our YouTube channel for more videos VISIT YOUTUBEBlog Articles The impact of AI on drug developmentAug 16, 2023 | BlogThe importance of Pricing and Market Access in licensing, partnering and early-stage developmentFeb 20, 2023 | BlogSo you know how to calculate and manage risk?Dec 7, 2022 | BlogHow to survive economic ‘Head Winds’!Jul 12, 2022 | BlogIs ‘closed-shop’ innovation a threat of new therapies and the fate of some pharma?Sep 16, 2021 | BlogVaccines, patents and supplyJun 1, 2021 | BlogPharmaVentures’ Industry Insight: We predict that licensing and partnering activity will remain steady in 2020Mar 26, 2020 | BlogAre you Planning to Divest R&D or Manufacturing Facilities?May 7, 2015 | BlogPharmaVentures are Media Partners at the World Stem Cells & Regenerative Medicine Congress 2015May 5, 2015 | BlogSeason’s Greetings from PharmaVentures 2014Jan 2, 2015 | BlogConvergence of Healthcare with ICT acceleratesOct 6, 2014 | BlogPfizer/AZ: The bigger issue is not M&A but how in the future we find effective medicinesMay 12, 2014 | Blog « Older Entries Our Termsheet Issue 39Oct 2, 2025 | TermsheetWhite Papers Dx Deal Review FY 2025: Part 1Apr 1, 2026 | White PapersOur News PharmaVentures Appoints a New Vice President – Samara Ferguson to Lead the Pricing & Market Access TeamJul 3, 2025 | Press Releases
PharmaVentures InSights: The impact of conference cancellations on dealmaking during the Covid-19 pandemicNov 11, 2020
Key Questions When Doing a Deal with Big Pharma: A Conversation with PharmaVentures (한국어 버전)Aug 31, 2018
The importance of Pricing and Market Access in licensing, partnering and early-stage developmentFeb 20, 2023 | Blog
Is ‘closed-shop’ innovation a threat of new therapies and the fate of some pharma?Sep 16, 2021 | Blog
PharmaVentures’ Industry Insight: We predict that licensing and partnering activity will remain steady in 2020Mar 26, 2020 | Blog
PharmaVentures are Media Partners at the World Stem Cells & Regenerative Medicine Congress 2015May 5, 2015 | Blog
Pfizer/AZ: The bigger issue is not M&A but how in the future we find effective medicinesMay 12, 2014 | Blog
PharmaVentures Appoints a New Vice President – Samara Ferguson to Lead the Pricing & Market Access TeamJul 3, 2025 | Press Releases